Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma
Fangzhou Liu, Tian Tian, Zhen Zhang, et al.
Nature Metabolism (2022) Vol. 4, Iss. 8, pp. 1022-1040
Closed Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

lincRNA00907 promotes NASH progression by targeting miRNA-942-5p/TAOK1
Gang Du, Zhaochen Jiang, Tong Xia, et al.
Aging (2024)
Open Access | Times Cited: 2
LINC00894 targets Annexin A2 to regulate oxaliplatin resistance in hepatocellular carcinoma: ANXA2 protein function
Junling Huang, Jiajie Lin, Tengmeng Zhong, et al.
International Journal of Biological Macromolecules (2024) Vol. 281, pp. 136538-136538
Closed Access | Times Cited: 2
Crosstalk between Noncoding RNAs and the Epigenetics Machinery in Pediatric Tumors and Their Microenvironment
Anup S. Pathania
Cancers (2023) Vol. 15, Iss. 10, pp. 2833-2833
Open Access | Times Cited: 6
Regulation of cholesterol homeostasis in osteoporosis mechanisms and therapeutics
Chuncha Bao, Tao Wu, Siyi Zhu, et al.
Clinical Science (2023) Vol. 137, Iss. 15, pp. 1131-1143
Closed Access | Times Cited: 6
The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma
Yuling Hong, Yunxing Zhang, Haibo Zhao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 10
Research progress on the role of cholesterol in hepatocellular carcinoma
Peng Li, Qi Yan, Zhaolin Chen, et al.
European Journal of Pharmacology (2022) Vol. 938, pp. 175410-175410
Closed Access | Times Cited: 8
Mobilization of cholesterol induces the transition from quiescence to growth in Caenorhabditis elegans through steroid hormone and mTOR signaling
Kathrin Schmeißer, Damla Kaptan, Bharath Kumar Raghuraman, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
A Novel Cholesterol Metabolism-Related lncRNA Signature Predicts the Prognosis of Patients with Hepatocellular Carcinoma and Their Response to Immunotherapy
Hui Lei, Tao Xiang, Hua Zhu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 1
Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons
Himanshi Goyal, Sachin Parwani, Jyotdeep Kaur
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation
Shuo Zhang, Yaning Shi, Jia Gu, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1108-1119
Open Access | Times Cited: 4
Clinical prospects and research strategies of long non-coding RNA encoding micropeptides
Xinyi Wang, Zhen Zhang, Chengyu Shi, et al.
Journal of Zhejiang University (Medical Sciences) (2023) Vol. 52, Iss. 4, pp. 397-405
Open Access | Times Cited: 2
The expression and function of long noncoding RNAs in hepatocellular carcinoma
Jingli Du, Yue Su, Gao Jianzhi, et al.
Cancer Innovation (2023) Vol. 2, Iss. 6, pp. 488-499
Open Access | Times Cited: 2
Predicting prognosis and immune status in sarcomas by identifying necroptosis-related lncRNAs
Zhen Wang, Anfang He, Zhengyu Lu, et al.
Aging (2024)
Open Access
The balance between antiviral and antibacterial responses duringM. Tuberculosisinfection is regulated by the ubiquitin ligase CBL
Tina Truong, Kelsey Martin, Michelle Salemi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma
Dongmei Wang, Yuxiang Cao, Meiyao Meng, et al.
PLoS Biology (2024) Vol. 22, Iss. 5, pp. e3002621-e3002621
Open Access
NKILA is a novel suppressor of local recurrence in women breast malignant phyllodes tumor patients via inhibition of the NF-κB pathway
Ying Mi, Le Yan, Haiyun Jin, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33259-e33259
Open Access
The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling pathway
Yu-Heng Zhu, Qin-Yuan Jia, Hong-Fei Yao, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo
Ruolin Zhao, Caiyun Zhang, Chenchen Tang, et al.
Journal of Ethnopharmacology (2024) Vol. 336, pp. 118706-118706
Closed Access
Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism
Zhicheng Li, Dan Wang, Xiaojun Zhu
Clinical & Translational Oncology (2024)
Closed Access
HMPA: a pioneering framework for the noncanonical peptidome from discovery to functional insights
Xinwan Su, Chengyu Shi, Fangzhou Liu, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 6
Open Access
Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis
Yue Gao, Shanpeng Zhang, Xianhong Zhang, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111359-111359
Open Access
mTOR-related linc-PMB promotes mitochondrial biogenesis via stabilizing SIRT1 mRNA through binding to the HuR protein
Qian Chen, Huaying Zhang, D.M. Wang, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD)
Qing Tao, Jing Xie, Yongkang Wu, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 5, pp. 506-516
Closed Access
SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics
Wenjie Feng, Yiling Jiang, Lijun Zeng, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access
SHP-1 alleviates acute liver injury caused by Escherichia coli sepsis through negatively regulating the canonical and non-canonical NFκB signaling pathways
Ningning Wang, Suxu Tan, Hongning Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113371-113371
Closed Access

Scroll to top